Xcell Therapeutics Inc. (KOSDAQ:373110)

South Korea · Delayed Price · Currency is KRW

1,368.00

-69.00 (-4.80%)

Apr 2, 2026, 3:30 PM KST

Revenue by Segment

Financials in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019
Pharmaceuticals	1.93B	1.12B	1.02B	1.97B	540.20M
Pharmaceuticals Growth	72.11%	10.18%	-48.12%	264.00%	531.11%
Total	1.93B	1.12B	1.02B	1.97B	540.20M
Total Growth	72.11%	10.18%	-48.12%	264.00%	531.11%

Revenue by Geography

Financials in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019
South Korea	1.73B	1.09B	959.98M	1.90B	526.17M
South Korea Growth	58.51%	13.47%	-49.47%	261.09%	514.73%
Overseas	207.75M	34.62M	60.06M	66.31M	14.02M
Overseas Growth	500.15%	-42.36%	-9.44%	372.92%	-
Total	1.93B	1.12B	1.02B	1.97B	540.20M
Total Growth	72.11%	10.18%	-48.12%	264.00%	531.11%

Source: S&P Global Market Intelligence.